{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:49:42Z","timestamp":1791254982346,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.cca.2014.12.011","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T18:08:29Z","timestamp":1418407709000},"page":"29-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines"],"prefix":"10.1016","volume":"441","author":[{"given":"Milanthy S.","family":"Pourier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Kapusta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-0105","authenticated-orcid":false,"given":"Aniek","family":"van Gennip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos P.M.","family":"B\u00f6kkerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Bellersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies M.C.","family":"Mavinkurve-Groothuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.12.011_bb0005","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","article-title":"Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia","volume":"23","author":"Lipshultz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cca.2014.12.011_bb0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2005.05759.x","article-title":"Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies","volume":"131","author":"Wouters","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cca.2014.12.011_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pcad.2010.04.002","article-title":"Role of biomarkers in chemotherapy-induced cardiotoxicity","volume":"53","author":"Cardinale","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cca.2014.12.011_bb0020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/08880010802244001","article-title":"The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature","volume":"25","author":"Mavinkurve-Groothuis","year":"2008","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.cca.2014.12.011_bb0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pbc.21633","article-title":"Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity","volume":"51","author":"Germanakis","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cca.2014.12.011_bb0030","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/pbc.21913","article-title":"Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines","volume":"52","author":"Mavinkurve-Groothuis","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cca.2014.12.011_bb0035","first-page":"116","article-title":"BNP in the diagnosis and risk stratification of heart failure","volume":"4","author":"Moe","year":"2005","journal-title":"Heart Fail Monit"},{"key":"10.1016\/j.cca.2014.12.011_bb0040","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.2174\/092986712800492968","article-title":"Predictive value of biomarkers in patients with heart failure","volume":"19","author":"Tousoulis","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cca.2014.12.011_bb0045","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2013.5809","article-title":"Increasingly sensitive assays for cardiac troponins: a review","volume":"309","author":"de Lemos","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2014.12.011_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1568026611313020008","article-title":"High sensitivity troponin in cardiovascular disease. Is there more than a marker of myocardial death?","volume":"13","author":"Tsounis","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.cca.2014.12.011_bb0055","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cca.2014.12.011_bb0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0002-9149(94)90503-7","article-title":"Use of mean arterial pressure for noninvasive determination of left ventricular end-systolic wall stress in infants and children","volume":"74","author":"Rowland","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2014.12.011_bb0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0735-1097(84)80397-6","article-title":"Left ventricular end-systolic wall stress\u2013velocity of fiber shortening relation: a load-independent index of myocardial contractility","volume":"4","author":"Colan","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.12.011_bb0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","article-title":"Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method","volume":"55","author":"Devereux","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.12.011_bb0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1373\/clinchem.2009.132654","article-title":"Analytical validation of a high-sensitivity cardiac troponin T assay","volume":"56","author":"Giannitsis","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.12.011_bb0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.amjcard.2011.06.057","article-title":"Reference limits for n-terminal-pro-b-type natriuretic peptide in healthy individuals (from the Framingham heart study)","volume":"108","author":"Fradley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2014.12.011_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00246-008-9258-4","article-title":"NT-pro-b-type natriuretic peptide in infants and children: reference values based on combined data from four studies","volume":"30","author":"Nir","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cca.2014.12.011_bb0090","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/CIRCULATIONAHA.112.100560","article-title":"Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues","volume":"126","author":"Khouri","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.12.011_bb0095","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1200\/JCO.2006.09.1611","article-title":"Trastuzumab-associated cardiac adverse effects in the Herceptin adjuvant trial","volume":"25","author":"Suter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cca.2014.12.011_bb0100","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.20.5.1215","article-title":"Cardiac dysfunction in the Trastuzumab clinical trials experience","volume":"20","author":"Seidman","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cca.2014.12.011_bb0105","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1253\/circj.CJ-13-0706","article-title":"Cardiac troponin T: from diagnosis of myocardial infarction to cardiovascular risk prediction","volume":"77","author":"Mueller","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.cca.2014.12.011_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2009.10.022","article-title":"Prognostic role of highly sensitive cardiac troponin i in patients with systolic heart failure","volume":"159","author":"Tsutamoto","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2014.12.011_bb0115","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","article-title":"Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure","volume":"116","author":"Latini","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.12.011_bb0120","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and Trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cca.2014.12.011_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-9966-31-13","article-title":"Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation","volume":"31","author":"Roziakova","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.cca.2014.12.011_bb0130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cca.2010.12.034","article-title":"Multicenter analytical evaluation of a high-sensitivity troponin T assay","volume":"412","author":"Saenger","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.12.011_bb0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1179\/joc.2007.19.3.332","article-title":"Cardiac troponin T following anthracycline chemotherapy in children and adolescents","volume":"19","author":"Clark","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.cca.2014.12.011_bb0140","first-page":"1197","article-title":"Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy","volume":"26","author":"Soker","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1016\/j.cca.2014.12.011_bb0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1179\/102453312X13376952196412","article-title":"Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children","volume":"17","author":"Sherief","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.cca.2014.12.011_bb0150","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0959-8049(01)00431-2","article-title":"Troponin T in the first 24hours after the administration of chemotherapy and the detection of myocardial damage in children","volume":"38","author":"Kremer","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cca.2014.12.011_bb0155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1651-2227.2006.00174.x","article-title":"Early prediction of anthracycline induced cardiotoxicity","volume":"96","author":"Erkus","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.cca.2014.12.011_bb0160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MPH.0b013e31826faf44","article-title":"Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer","volume":"34","author":"Pongprot","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cca.2014.12.011_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/pbc.10368","article-title":"Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin","volume":"42","author":"Kismet","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cca.2014.12.011_bb0170","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1200\/JCO.2010.30.3404","article-title":"Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes","volume":"30","author":"Lipshultz","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cca.2014.12.011_bb0175","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin i in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.12.011_bb0180","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ehjci\/jes217","article-title":"Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study","volume":"14","author":"Mavinkurve-Groothuis","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cca.2014.12.011_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/157339412800675342","article-title":"Preventing and treating anthracycline-related cardiotoxicity in survivors of childhood cancer","volume":"8","author":"Diamond","year":"2012","journal-title":"Curr Cancer Ther Rev"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114005452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114005452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T21:24:18Z","timestamp":1537997058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114005452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":37,"alternative-id":["S0009898114005452"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.12.011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}